Markus Raderer

4k citations
75 papers · 3.1k · 1 hit paper · h-index 25

Impact in

Papers in

    • Pancreatic and Hepatic Oncology Research 4
    • Cancer survivorship and care 3
    • Neuroendocrine Tumor Research Advances 17

Markus Raderer

74 papers receiving 3k citations

Markus Raderer's Hit Papers

Everolimus for the treatment of advanced, non-functional neuroendocrine tumours of the lung or gastrointestinal tract (RADIANT-4): a randomised, placebo-controlled, phase 3 study 2015 · 999 citations
9990+3+7Years since publication250500750

Peers

Markus Raderer
Comparison fields: 5 of 84
  • Epidemiology 1.1k
  • Pathology and Forensic Medicine 285
  • Hepatology 128
  • Oncology 312
  • Pulmonary and Respiratory Medicine 359
Replace François Paraf with:
François Paraf France
Sofia Asioli Italy
Motomu Tsuji Japan
Silvia Uccella Italy
Reda S. Saad United States
Takashi Koshikawa Japan
Christiane De Wolf‐Peeters Belgium
Maria Pia Brizzi Italy
Toshiharu Matsumoto Japan
Andrew R. Heryet United Kingdom
Markus Raderer relative to François Paraf France François Paraf's profile →
Citations per field
00.5×2×4×5.2×
François Paraf · 1×
Citations per year

Countries citing papers authored by Markus Raderer

Since Specialization
Citations

This map shows the geographic impact of Markus Raderer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Raderer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Raderer more than expected).

Fields of papers citing papers by Markus Raderer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Markus Raderer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Raderer. The network helps show where Markus Raderer may publish in the future.

Co-authors

The 25 scholars most cited alongside Markus Raderer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Markus Raderer Line = papers co-authored together Markus Raderer links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 75 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Everolimus for the treatment of advanced, non-functional neuroendocrine tumours of the lung or gastrointestinal tract (RADIANT-4): a randomised, placebo-controlled, phase 3 study
Hit paper breakdown →
2015999
2 2003266
3
Imaging of advanced neuroendocrine tumors with (18)F-FDOPA PET.
2004162
4 2021142
5 201399
6 199893
7 201291
8 199488
9
Templated nucleotide addition and immunoglobulin JH-gene utilization in t(11;14) junctions: implications for the mechanism of translocation and the origin of mantle cell lymphoma.
200184
10 200276
11 201768
12
Palliative chemotherapy for recurrent and metastatic esophageal cancer.
200766
13 200861
14 200157
15 199954
16 200142
17
New trends in peptide receptor radioligands.
200139
18 201738
19 201635
20 200634

About Markus Raderer

Markus Raderer is a scholar working on Oncology, Epidemiology, Pathology and Forensic Medicine, Radiology, Nuclear Medicine and Imaging and Dermatology, having authored 75 papers that have together received 3.1k indexed citations. Recurring topics across this work include Neuroendocrine Tumor Research Advances (17 papers), Lymphoma Diagnosis and Treatment (11 papers), Radiopharmaceutical Chemistry and Applications (6 papers), Medical Imaging Techniques and Applications (6 papers), Pancreatic and Hepatic Oncology Research (4 papers), Chronic Lymphocytic Leukemia Research (4 papers), Lung Cancer Diagnosis and Treatment (3 papers) and Cancer survivorship and care (3 papers). The work is most often cited by research in Epidemiology (1.1k citations), Pathology and Forensic Medicine (285 citations), Hepatology (128 citations), Oncology (312 citations) and Pulmonary and Respiratory Medicine (359 citations). Markus Raderer has collaborated with scholars based in Austria, United States and Switzerland. Frequent co-authors include Werner Scheithauer, Michael Hejna, Amir Kurtaran, Peter Angelberger, Christian Albert Mueller, Robert Dudczak, Wolfgang Fiebiger, Gerhard Hamilton, L H Block and Ventzislav Petkov. Their work appears in journals such as European Journal of Cancer, Annals of Oncology, Oncology, JNCI Journal of the National Cancer Institute and Haematologica.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact